Last reviewed · How we verify

Periarticular Injection (PAI)

Hospital for Special Surgery, New York · FDA-approved active Small molecule

Periarticular injection delivers therapeutic agents directly into the tissue surrounding a joint to reduce inflammation and pain during or after orthopedic surgery.

Periarticular injection delivers therapeutic agents directly into the tissue surrounding a joint to reduce inflammation and pain during or after orthopedic surgery. Used for Perioperative pain management in orthopedic surgery (e.g., total knee arthroplasty, total hip arthroplasty), Postoperative analgesia and inflammation reduction.

At a glance

Generic namePeriarticular Injection (PAI)
SponsorHospital for Special Surgery, New York
ModalitySmall molecule
Therapeutic areaOrthopedic Surgery / Pain Management
PhaseFDA-approved

Mechanism of action

PAI is a surgical technique rather than a discrete drug entity, involving infiltration of local anesthetics, corticosteroids, and/or other anti-inflammatory agents into the soft tissues around a joint. This localized delivery reduces postoperative pain, swelling, and opioid consumption while potentially improving functional recovery. The approach is commonly used in joint replacement and arthroscopic procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: